![Karin Eklund Vanderpol](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karin Eklund Vanderpol
General Counsel at
VICORE PHARMA HOLDING AB
Profile
Karin Eklund Vanderpol is currently Vice President-Regulatory Affairs at Vicore Pharma Holding AB since 2022.
Former positions include Director-Global Regulatory Affairs at Swedish Orphan Biovitrum AB, Head-Regulatory Affairs at AstraZeneca AB, and Head-Regulatory Affairs at Oncopeptides AB from 2020 to 2022.
Education includes a graduate degree from the University of Uppsala.
Karin Eklund Vanderpol active positions
| Companies | Position | Start |
|---|---|---|
| VICORE PHARMA HOLDING AB | General Counsel | 31/12/2021 |
Former positions of Karin Eklund Vanderpol
| Companies | Position | End |
|---|---|---|
| ONCOPEPTIDES AB | General Counsel | 31/12/2021 |
| SWEDISH ORPHAN BIOVITRUM AB | General Counsel | 30/11/2019 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | General Counsel | - |
Training of Karin Eklund Vanderpol
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Vicore Pharma Holding AB
 Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
- Stock Market
- Insiders
- Karin Eklund Vanderpol
